Join our 3-part Liquid Biopsy Online webinar series. Explore MRD, multi-omics, and adaptive oncology to unlock the future of ...

We’re delighted to have had the chance to speak to genomics pioneer Leroy Hood, ahead of his talk at The Festival of Genomics ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Endometriosis is a chronic gynecological condition in which tissue similar to the uterine lining grows outside the uterus, most commonly in the pelvis. Affecting millions of women worldwide, the ...

Pharmacogenomics has transformed how clinicians reduce adverse drug reactions and optimise therapy. But real-world implementation still faces significant limitations. Can’t make the scheduled session?

The metabolome consists of all the small molecules, or metabolites, which are components and products of biochemical reactions taking place within the body. Given its dynamic nature, metabolomics is a ...

This feature was written using content from out recenty published Proteomics Playbook, which you can download for FREE here. The sequence of a protein is critical as it largely dictates the protein’s ...

This year’s Nobel Prize winners have been announced, highlighting revolutionary breakthroughs in science. This year Prize in Medicine was awarded to Victor Ambros and Gary Ruvkun “for the discovery of ...

Next generation sequencing (NGS) is a powerful tool for uncovering a patient’s inherited susceptibility to cancer, paving the way for more effective prevention strategies. However, hereditary cancer ...

Got five minutes to read the latest news from the genomics world and beyond? Week in Brief has everything you need! In a bid to better understand the potential of AI in healthcare settings, ...

How will multi-omics change healthcare? With new ways to integrate data, new applications in precision medicine, and the emerging potential of AI and machine learning for analysis, it is an exciting ...

As technology advances, we’re used to hearing about the latest in a seemingly never-ending list of ‘omics’. With each one hailed as more promising than the last, opportunities in the life sciences ...